Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VBI Vaccines Inc.    VBIV   CA91822J1030

VBI VACCINES INC.

(VBIV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 274156246673--
Entreprise Value (EV)1 274156246673673673
P/E ratio -4,85x-1,65x-3,00x-15,9x-14,7x-27,3x
Yield ------
Capitalization / Revenue 316x46,4x111x515x100x24,1x
EV / Revenue 316x46,4x111x515x100x24,1x
EV / EBITDA ------
Price to Book ------
Nbr of stocks (in thousands) 64 07997 344178 257231 198--
Reference price (USD) 4,271,601,382,912,912,91
Last update 02/26/201802/25/201903/05/2020---
1
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 0,873,362,221,316,7127,9
EBITDA ------
Operating profit (EBIT)1 -37,3-60,4-52,4-38,1-47,0-25,4
Operating Margin -4 310%-1 801%-2 359%-2 914%-700%-91,2%
Pre-Tax Profit (EBT)1 -39,4-63,6-54,8-40,7-51,0-29,1
Net income1 -39,0-63,6-54,8-38,2-45,8-26,4
Net margin -4 508%-1 896%-2 468%-2 922%-683%-94,6%
EPS2 -0,88-0,97-0,46-0,18-0,20-0,11
Dividend per Share ------
Last update 02/26/201802/25/201903/05/2020---
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 ---7,45-40,5-39,1
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share ------
Capex1 0,645,993,670,790,580,58
Capex / Sales 74,0%179%165%60,4%8,57%2,09%
Last update 02/26/201802/25/201903/05/202008/27/202008/27/202008/27/2020
1 USD in Million
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
672 787 332
Net sales (USD)
2 221 000
Number of employees
124
Sales / Employee (USD)
17 911
Free-Float
72,5%
Free-Float capitalization (USD)
487 838 217
Avg. Exchange 20 sessions (USD)
59 353 712
Average Daily Capital Traded
8,82%
EPS & Dividend